Latest news with #NatcoPharmaLtd
Business Standard
2 days ago
- Business
- Business Standard
Natco Pharma Ltd spurts 0.35%, gains for five straight sessions
Natco Pharma Ltd is quoting at Rs 1036.4, up 0.35% on the day as on 12:44 IST on the NSE. The stock is down 15.28% in last one year as compared to a 1.65% gain in NIFTY and a 10.63% gain in the Nifty Pharma. Natco Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 1036.4, up 0.35% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.7% on the day, quoting at 24936.3. The Sensex is at 81666.8, down 0.72%. Natco Pharma Ltd has added around 17.56% in last one month. Meanwhile, Nifty Pharma index of which Natco Pharma Ltd is a constituent, has added around 5.38% in last one month and is currently quoting at 22680.35, down 0.37% on the day. The volume in the stock stood at 9.39 lakh shares today, compared to the daily average of 15.16 lakh shares in last one month. The PE of the stock is 10 based on TTM earnings ending March 25.
Mint
03-07-2025
- Business
- Mint
Nagaraj Shetti suggests Havells India, Natco Pharma shares to buy in the short term; do you own?
Stock market today: Indian stock markets showed an upward trend on Thursday, but caution lingered as investors expressed concerns over the impending US tariff deadline. As of 12:45 IST, the Nifty 50 index stood at 25,505.10, up by 51.70 points or 0.20%. Likewise, the BSE Sensex reached 83,540.74, reflecting a slight increase of 131.05 points or 0.16%. Market analysts pointed out that while domestic influences are bolstering the market, global fluctuations, particularly the uncertainties surrounding the US-India trade agreement, are keeping traders on high alert. On the technical front, Nagaraj Shetti of HDFC Securities, believes the next overhead resistance for Nifty 50 is to be watched around 25,700 levels. Shetti recommends two stocks to buy in the short-term. Here's what he says about the overall market. After showing minor downward correction in the last few sessions, Nifty 50 has bounced back on Thursday and is currently trading higher by 95 points. Bullish pattern like higher tops and bottoms is intact on the daily chart and the recent swing low of 25,378 could be considered as a new higher bottom of the pattern. Nifty 50 is currently placed at the support of ascending trend line around 25,400 levels. The next overhead resistance to be watched around 25,700 levels. Nagaraj Shetti of HDFC Securities recommends these two stocks to buy in the short-term - Havells India Ltd, and Natco Pharma Ltd. After showing minor downward correction in the last few sessions, Havells India share price has shifted into a sustainable bounce so far on Thursday. The present upmove could push the stock price towards the breakout of 200day EMA at ₹ 1600 levels soon. Bullish pattern like higher tops and bottoms is intact on the daily chart. Natco Pharma share price has been moving in a larger consolidation band over the last few months. Presently, the stock price is in an attempt of upside breakout of triangle pattern at ₹ 955 levels. Rise in volume and positive RSI indicates more upside for the short term. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Business Standard
11-06-2025
- Business
- Business Standard
Natco Pharma Ltd gains for third consecutive session
Natco Pharma Ltd is quoting at Rs 908.15, up 3.01% on the day as on 12:49 IST on the NSE. The stock is down 22.31% in last one year as compared to a 8.09% spurt in NIFTY and a 11.76% spurt in the Nifty Pharma index. Natco Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 908.15, up 3.01% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.42% on the day, quoting at 25209.65. The Sensex is at 82725.53, up 0.41%. Natco Pharma Ltd has risen around 8.92% in last one month. Meanwhile, Nifty Pharma index of which Natco Pharma Ltd is a constituent, has risen around 4.53% in last one month and is currently quoting at 21948, up 0.51% on the day. The volume in the stock stood at 13.07 lakh shares today, compared to the daily average of 7.32 lakh shares in last one month. The PE of the stock is 8.53 based on TTM earnings ending March 25.
Business Standard
24-04-2025
- Business
- Business Standard
Volumes spurt at Syngene International Ltd counter
Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceuticals Ltd are among the other stocks to see a surge in volumes on NSE today, 24 April 2025. Syngene International Ltd registered volume of 168.31 lakh shares by 14:14 IST on NSE, a 34.31 fold spurt over two-week average daily volume of 4.91 lakh shares. The stock slipped 12.51% to Rs.655.45. Volumes stood at 6.35 lakh shares in the last session. Natco Pharma Ltd clocked volume of 144.27 lakh shares by 14:14 IST on NSE, a 34.05 times surge over two-week average daily volume of 4.24 lakh shares. The stock gained 8.94% to Rs.920.00. Volumes stood at 3.69 lakh shares in the last session. Newgen Software Technologies Ltd saw volume of 117.97 lakh shares by 14:14 IST on NSE, a 28.87 fold spurt over two-week average daily volume of 4.09 lakh shares. The stock increased 13.03% to Rs.1,122.60. Volumes stood at 14 lakh shares in the last session. MMTC Ltd registered volume of 410.32 lakh shares by 14:14 IST on NSE, a 26.01 fold spurt over two-week average daily volume of 15.78 lakh shares. The stock rose 14.15% to Rs.63.73. Volumes stood at 14.89 lakh shares in the last session. Glaxosmithkline Pharmaceuticals Ltd recorded volume of 17.98 lakh shares by 14:14 IST on NSE, a 14.9 times surge over two-week average daily volume of 1.21 lakh shares. The stock gained 3.19% to Rs.2,937.50. Volumes stood at 85241 shares in the last session.
